You are here: Home » Companies » News
Business Standard

Laurus Labs gets USFDA nod for Visakhapatnam unit

The firm is one of the leading manufacturers of APIs for anti-retroviral (ARV), Hepatitis C, and Oncology

BS Reporter  |  Hyderabad 

Laurus Labs
Laurus Labs

Hyderabad-based Limited has received the (EIR) from (USFDA) for its formulations and active pharmaceutical ingredient (API) manufacturing plant, Unit 2 located in The inspection was completed in May, 2017.

Meanwhile, the German Regulatory Authority has also completed the inspection of Unit 2, while the World Health Organisation(WHO) has completed the inspection of Unit 1 and 3 in May 2017, according to the company.

Laurus is one of the leading manufacturers of APIs for anti-retroviral (ARV), Hepatitis C, and Oncology among other therapeutic areas.

First Published: Fri, September 15 2017. 20:27 IST
RECOMMENDED FOR YOU